4//SEC Filing
Haddadin Yezan Munther 4
Accession 0001415889-24-009394
CIK 0001649989other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 10:39 AM ET
Size
5.5 KB
Accession
0001415889-24-009394
Insider Transaction Report
Form 4
Haddadin Yezan Munther
Director
Transactions
- Purchase
Common Stock
2024-03-28$11.82/sh+1,881.711$22,242→ 5,048.711 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $11.78 to $11.8249 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]Reflects the Issuer's 1-for-20 reverse stock split effected on March 13, 2024.
Documents
Issuer
Outlook Therapeutics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001718004
Filing Metadata
- Form type
- 4
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 10:39 AM ET
- Size
- 5.5 KB